Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Vijay R. Varma(National Institutes of Health), Madhav Thambisetty(National Institutes of Health), Gabi Kastenmueller(Helmholtz Zentrum München), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Rebecca Baillie(Rosa (United States)), Ramon Casanova(Wake Forest University), Cristina Legido‐Quigley(Steno Diabetes Centers), Juan C. Troncoso(Johns Hopkins University), Jon B. Toledo(Methodist Hospital), Matthias Arnold(Duke University), Olga Pletniková(Johns Hopkins University), Ryan M. Andrews(Johns Hopkins University), Anup Mammen Oommen, Kwangsik Nho(Indiana University School of Medicine), Yang An(Nanjing University), Richard O’Brien(Duke University), Sudhir Varma, P. Murali Doraiswamy(Alzheimer’s Disease Neuroimaging Initiative), Rima Kaddurah‐Daouk(Duke University)
Cited by 496
Related Papers
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
Hearing Loss and Incident Dementia
|Archives of Neurology|2011|1.5k
Primary age-related tauopathy (PART): a common pathology associated with human aging
|Acta Neuropathologica|2014|1.5k